British study shows Covid-19 vaccine efficacy wanes under Delta

Published
0

A British public health study has found that protection from either of the two most commonly used Covid-19 vaccines against the now prevalent Delta variant of the coronavirus weakens within three months, Reuters reports.

The Oxford University study found that 90 days after a second shot of the Pfizer or Astrazeneca vaccine, their efficacy in preventing infections had slipped to 75 per cent and 61pc respectively. The decline in efficacy was more pronounced among those aged 35 years and older than those below that age.

Opinion

Editorial

Talks, at last
03 Oct, 2026

Talks, at last

YESTERDAY, the government and opposition finally sat across from each other and talked. A government-led coalition,...
IWT’s future
03 Oct, 2026

IWT’s future

TOGETHER with the Kashmir dispute, India’s unilateral suspension of the Indus Waters Treaty has become the biggest...
Pained minds
03 Oct, 2026

Pained minds

IN Pakistan, mental healthcare is wedged between two extremes — a luxury or a stigma. Estimates cited by the...
Risks ahead
Updated 02 Oct, 2026

Risks ahead

To think that the government would rather push out an elected government than grant a single prisoner some facilities does not square up rationally.
Exit from Iraq
02 Oct, 2026

Exit from Iraq

AMERICAN and British troops have once again shipped out of Iraq. On Wednesday, the foreign forces left the Arab...
Lahore’s ozone warning
02 Oct, 2026

Lahore’s ozone warning

LAHORE has received another warning that its air pollution crisis cannot be treated as a problem that begins with...